The Department of Defense is offering the Tuberous Sclerosis Complex Clinical Translational Research Award to support studies bridging basic and clinical science to enhance the diagnosis, prognosis, or treatment of TSC. This grant is aimed at funding projects that transition from preclinical to clinical research or vice versa, including pilot clinical trials and correlative studies. Researchers can utilize human anatomical substances and clinical trial data to develop models for translational research with the potential to impact clinical outcomes. The closing date for applications is August 2, 2018.
Opportunity ID: 305065
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-18-TSCRP-CTRA |
| Funding Opportunity Title: | DoD Tuberous Sclerosis Complex Clinical Translational Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 14, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 02, 2018 |
| Current Closing Date for Applications: | Aug 02, 2018 |
| Archive Date: | Sep 01, 2018 |
| Estimated Total Program Funding: | $6,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The Clinical Translational Research Award supports forward and/or reverse clinical/translational studies that have a reciprocal flow of ideas and information between basic and clinical science and have the potential to improve the diagnosis, prognosis, or treatment of TSC. Projects supported by this award mechanism may include studies moving from preclinical to clinical research (including a pilot clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with clinical trials (such as correlative studies) to develop models that recapitulate relevant clinical outcomes for use in translational research. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 305065 Full Announcement-FY18 TSCRP CTRA -> TSCRP_FY18_CTRA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00242090 | May 14, 2018 | Aug 02, 2018 | View |
Package 1
Mandatory forms
305065 RR_SF424_2_0-2.0.pdf
305065 AttachmentForm_1_2-1.2.pdf
305065 RR_PersonalData_1_2-1.2.pdf
305065 RR_KeyPersonExpanded_2_0-2.0.pdf
305065 RR_Budget_1_4-1.4.pdf
305065 PerformanceSite_2_0-2.0.pdf
Optional forms
305065 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
